Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Phase I Clinical Trial of CA-4948 (Emavusertib) in Combination with FOLFOX Plus Bevacizumab as Frontline Treatment in Patients with Metastatic Colorectal Cancer

Multiple Cancer Types

Disease Sites: Colon, Phase I, Rectal

Phase: I

Investigator: Ciombor, Kristen

NCTID: NCT06696768

Protocol No: ETCGIP10655

Phase 3 Multicenter, Randomized, Open-label, Active-Controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-nave Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

Disease Sites: Not Available

Phase: III

Investigator: Eng, Cathy

NCTID: NCT06252649

Protocol No: VICC-DTGIT23266

A Phase III Trial of One vs. Two Years of Maintenance Olaparib, With or Without Bevacizumab, in Patients With BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum Based Chemotherapy

Multiple Cancer Types

Disease Sites: Gynecologic, Ovarian

Phase: III

Investigator: Crispens, Marta

NCTID: NCT06580314

Protocol No: NRGGYNGY036

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form